Doctor insights on:
What is a better treatment for age-related macular degeneration, avastin or lucentis (ranibizumab)?
What of these treatments is cheaper?
Equivalent: Currently they seem equivalent although an nih study currently in progress can answer if one is better than the other. Avastin (bevacizumab) is considerably cheaper although the cost may be disguised by insurance coverage. You can trust your retinal surgeon to do the best thing. ...Read moreSee 1 more doctor answer
Usually: If one has Medicare as insurance, macular pucker is usually a covered diagnosis, and surgery is considered medically necessary if the patient is symptomatic or has vision deterioration from the pucker. People are Medicare eligible at age 65 years, or with certain chronic illnesses. ...Read more
Identical: Data on Bevacizumab or Erbitux in patients with metastatic colorectal cancer, patients who do not have a KRAS 12/13 gene mutation, have nearly identical survival rates. These identical results were seen after chemotherapy, where survival with chemo alone was about 5 months vs. 7-8 months using either bevacizumab (Avastin) or cetuximab (Erbitux). ...Read more
Cimzia (certolizumab pegol): Certolizumab, a biological drug, very expensive, used to treat some auto-immune diseases in selected cases ...Read more
What would be the reason to have prp laser on non-perfused peripheral retina.In crvo.? Ischemic.Already having lucentis (ranibizumab)..Could this affect va.
Depends on cause: I am assuming Avastin (bevacizumab) is being asked about. It is used to treat many causes of macular edema, including from diabetic retinopathy, retinal vein occlusions (central and brach vein). Macular edema from inflammation does not respond (well) to Avastin (bevacizumab). Avastin (bevacizumab) is used most commonly for the treatment of Age Related Macular Degeneration. Hope this helps. ...Read more
Yes: These two will not interact.Get a more detailed answer ›